PharmaHub · Other Pharma & Biotech · Asia Pacific

India Pharmaceutical Logistics Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The India pharmaceutical logistics market encompasses the specialized storage, transportation, and distribution services required to move temperature-sensitive drugs, vaccines, and other pharmaceutical products across domestic and international supply chains. The market was valued at approximately $4.04 billion in 2024 and is projected to reach roughly $10.4 billion by 2033, reflecting robust underlying demand. This growth is driven by India's position as a global pharmaceutical manufacturing hub, with the broader industry targeting $130 billion by 2030, alongside rising domestic healthcare consumption and expanding vaccine distribution networks.

Market size · 2025
$182 billion
CAGR · 2025–2030
5.8%
Forecast · 2030
$241 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $182bn2030 est: $241bn
Read the full India Pharmaceutical Logistics Market report →

Market Overview

India's pharmaceutical logistics market provides end-to-end supply chain solutions for one of the world's largest generic drug producers, handling everything from raw material inbound to finished-goods distribution across 28,000+ hospitals and 100,000+ retail outlets. The market generated approximately $4.04 billion in revenue in 2024 and is on a trajectory to exceed $10 billion by 2033, underpinned by India's status as the 'pharmacy of the world.' Logistics providers in this segment must comply with stringent GDP (Good Distribution Practice) guidelines enforced by the Central Drugs Standard Control Organization.

  • Market valued at ~$4.04 billion in 2024, projected to reach ~$10.4 billion by 2033
  • Supports India's $60 billion+ pharmaceutical industry, which targets $130 billion by 2030
  • Requires compliance with GDP standards, cold chain protocols, and serialization regulations

Growth Drivers

The expansion of India's domestic pharmaceutical manufacturing capacity, backed by production-linked incentive (PLI) schemes, is generating significant volumes that require sophisticated logistics support across the country. Growing vaccine production and distribution, particularly for routine immunization and pandemic preparedness, has accelerated investment in cold chain infrastructure, with temperatures ranging from +2°C to +8°C and, in some cases, deep-frozen storage below -60°C. Rising exports to regulated markets including the US, EU, and ASEAN demand logistics partners capable of meeting international quality standards and maintaining consistent product integrity throughout transit.

  • PLI schemes and Make in India initiatives are expanding domestic pharma manufacturing output
  • Vaccine rollout programs and growing biotech sector are driving cold chain logistics investment
  • Export growth to regulated markets requires GDP-compliant logistics and real-time tracking capabilities
Want a deeper cut on India Pharmaceutical Logistics Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is segmented by service type into transportation, warehousing, packaging, and value-added services such as serialization and temperature monitoring. Temperature control requirements divide the market into ambient (accounting for the largest share), cold chain (2-8°C), and ultra-low temperature segments. Geographically, demand clusters around pharmaceutical hubs including Hyderabad and Bengaluru in the south, Ahmedabad and Mumbai in the west, and increasingly in emerging corridors in eastern and northern India. The organized segment is growing faster as pharma companies prefer compliant, auditable logistics partners for regulated product flows.

  • Transportation dominates service-type share, followed by warehousing and value-added packaging
  • Ambient logistics holds the largest segment; cold chain is the fastest-growing sub-segment
  • Key pharma corridors: Hyderabad, Ahmedabad, Mumbai, Bengaluru, and emerging eastern hubs

Trends and Outlook

What are the recent trends and outlook?

Digitalization is reshaping the sector, with IoT-based temperature sensors, blockchain for traceability, and AI-driven route optimization becoming standard offerings rather than premium services. The government's push for a unified pharma logistics framework and the implementation of serialization and track-and-trace mandates are expected to drive consolidation toward larger, technology-enabled operators. Contract logistics arrangements are expanding as pharmaceutical companies outsource end-to-end supply chain functions rather than managing logistics in-house. Looking forward, the convergence of biologics, biosimilars, and vaccine manufacturing in India is likely to sustain above-industry-average growth rates for the logistics segment well into the next decade.

  • IoT sensors, blockchain traceability, and AI-powered route optimization are becoming industry standards
  • Serialization mandates and track-and-trace regulations are pushing pharma companies toward compliant logistics partners
  • Contract logistics and outsourced supply chain models are expanding as the market matures
Talk to a Claight analyst
Do you want to research India Pharmaceutical Logistics Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.